NL302572A - - Google Patents

Info

Publication number
NL302572A
NL302572A NL302572DA NL302572A NL 302572 A NL302572 A NL 302572A NL 302572D A NL302572D A NL 302572DA NL 302572 A NL302572 A NL 302572A
Authority
NL
Netherlands
Application number
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Publication of NL302572A publication Critical patent/NL302572A/xx

Links

NL302572D 1962-12-27 NL302572A (enrdf_load_html_response)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
JP5790262 1962-12-27
JP6427663 1963-10-29
JP5741963 1963-10-29
JP6250163 1963-11-22

Publications (1)

Publication Number Publication Date
NL302572A true NL302572A (enrdf_load_html_response)

Family

ID=27463499

Family Applications (1)

Application Number Title Priority Date Filing Date
NL302572D NL302572A (enrdf_load_html_response) 1962-12-27

Country Status (5)

Country Link
BE (1) BE641880A (enrdf_load_html_response)
FR (1) FR3150M (enrdf_load_html_response)
GB (1) GB1080599A (enrdf_load_html_response)
LU (1) LU45106A1 (enrdf_load_html_response)
NL (1) NL302572A (enrdf_load_html_response)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2495608A1 (fr) * 1980-12-04 1982-06-11 Morelle Jean Nouveaux derives de l'acide aspartique et leurs usages
DK2319581T3 (en) 2004-11-26 2015-06-01 Ucl Business Plc Compositions comprising ornithine and phenylacetate phenylbutyrate OR TREATMENT hepatic encephalopathy
SG174982A1 (en) 2009-04-03 2011-11-28 Ocera Therapeutics Inc L-ornithine phenyl acetate and methods of making thereof
CA2764587C (en) 2009-06-08 2018-04-24 Ucl Business Plc Treatment of portal hypertension and restoration of liver function using l-ornithine phenylacetate
CN103502203B (zh) 2010-10-06 2016-09-07 欧塞拉治疗有限公司 制备l-鸟氨酸苯基乙酸盐的方法
EA201790913A1 (ru) 2014-11-24 2017-11-30 Юсл Бизнес Плс Лечение заболеваний, связанных с активацией звездчатых клеток печени, с применением видов терапии, снижающих уровень аммиака
WO2017031131A1 (en) 2015-08-18 2017-02-23 Ocera Therapeutics, Inc. Treatment and prevention of muscle loss using l-ornithine in combination with at least one of phenylacetate and phenylbutyrate
AU2018266357B2 (en) 2017-05-11 2022-12-08 Ocera Therapeutics, Inc. Processes of making L-ornithine phenylacetate
CN107540413A (zh) * 2017-09-14 2018-01-05 精晶药业股份有限公司 一种从门冬氨酸鸟氨酸结晶母液中提取尿素的方法

Also Published As

Publication number Publication date
BE641880A (enrdf_load_html_response) 1964-04-16
FR3150M (fr) 1965-02-22
LU45106A1 (enrdf_load_html_response) 1964-02-24
GB1080599A (en) 1967-08-23

Similar Documents

Publication Publication Date Title
BE616548R (enrdf_load_html_response)
BE631769A (enrdf_load_html_response)
BE489310A (enrdf_load_html_response)
AU269855A (enrdf_load_html_response)
BE632172A (enrdf_load_html_response)
BE538252A (enrdf_load_html_response)
BE538831A (enrdf_load_html_response)
BE541929A (enrdf_load_html_response)
BE553896A (enrdf_load_html_response)
BE559145A (enrdf_load_html_response)
BE586180A (enrdf_load_html_response)
BE592434A (enrdf_load_html_response)
BE599783A (enrdf_load_html_response)
BE604335A (enrdf_load_html_response)
BE608197A (enrdf_load_html_response)
BE609543A (enrdf_load_html_response)
BE612190A (enrdf_load_html_response)
BE612311A (enrdf_load_html_response)
BE612464A (enrdf_load_html_response)
BE612847A (enrdf_load_html_response)
BE612926A (enrdf_load_html_response)
BE613108A (enrdf_load_html_response)
BE613190A (enrdf_load_html_response)
BE613298A (enrdf_load_html_response)
BE613319A (enrdf_load_html_response)